CDChristian Delcour

Christian Delcour

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christian Delcour has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Two Rare Cases of Posttraumatic Peripheral Artery Pseudoaneurysm

    by Stéphanie Elens, Nicolas Bossu, Pierre Puech, Johan Ghekiere, Christian Delcour, Jan Casselman

    Posttraumatic pseudoaneurysms of the lower limb are increasingly recognized due to the development of cross-sectional imaging. Two cases of anterior tibial artery pseudoaneurysm after blunt trauma are presented. The diagnostic technique of choice is Doppler ultrasound (US). In some cases, computed tomography angiography (CTA) or magnetic resonance angiography (MRA) is needed to identify the feeding vessel. The treatment of choice is not yet determined. Ultrasound-guided thrombin injection is widely used as first-line treatment, but some cases are refractory to this treatment. Further investigation and optimization of therapeutic technique to definitely exclude the pseudoaneurysm from the circulation may result in faster and more cost-effective treatment than US-guided thrombin injection.


  • Open Access

    Predictive value of the RIFLE urine output criteria on contrast-induced nephropathy in critically ill patients

    by Aldjia Hocine, Pierre Defrance, Jacques Lalmand, Christian Delcour, Patrick Biston, Michaël Piagnerelli

    To investigate the predictive value of decreased urine output based on the Risk of renal dysfunction, Injury to the kidney, Failure of kidney function, Loss of kidney function and End-stage renal disease (RIFLE) classification on contrast- induced acute kidney injury (CA-AKI) in intensive care (ICU) patients. All patients who received contrast media (CM) injection for CT scan or coronary angiography during a 3-year period in a 24 bed medico-surgical ICU were reviewed. Daily serum creatinine concentrations and diuresis were measured for 3 days after CM injection. We identified 23 cases of CA-AKI in the 149 patients included (15.4 %). Patients who developed CA-AKI were more likely to require renal replacement therapy and had higher ICU mortality rates. At least one RIFLE urine output criteria was observed in 45 patients (30.2 %) and 14 of these 45 patients (31.1 %) developed CA-AKI based on creatinine concentrations. In 30 % of these cases, urine output decreased or didn’t change after the increase in creatinine concentrations. The RIFLE urine output criteria had low sensitivity (39.1 %) and specificity (67.9 %) for prediction of CA-AKI, a low positive predictive value of 50 % and a negative predictive value of 87.2 %. The maximal dose of vasopressors before CM was the only independent predictive factor for CA-AKI. CA-AKI is a frequent pathology observed in ICU patients and is associated with increased need for renal replacement therapy and increased mortality. The predictive value of RIFLE urine output criteria for the development of CA-AKI based on creatinine concentrations was low, which limits its use for assessing the effects of therapeutic interventions on the development and progression of AKI.


  • Incompatibility of Contrast Medium and Trisodium Citrate

    by Christian Delcour, Guy Bruninx

    To test the compatibility of trisodium citrate, a catheter lock solution, with iodinated contrast medium. Iohexol, iobitridol, iodixanol, ioxaglate, ioxithalamate, iomeprol, and iopromide were tested. In all tests, 2 ml of contrast medium were mixed with 2 ml of trisodium citrate solution. Iodixanol and ioxaglate provoked a highly viscous gluelike precipitation when mixed with trisodium citrate. A brief transient precipitate was observed with iohexol, iomeprol, and ioxithalamate. Permanent precipitation occurred with iobitridol and iopromide. One must be aware of the potential for precipitation when contrast medium is mixed with trisodium citrate solution. Before trisodium citrate solution is injected, the catheter should be thoroughly flushed with saline if a contrast medium has previously been injected through it.

  • Mobile aortic arch thrombus: Conservative management with ticlopidine?

    by Philippe Dubois, Patrick Gurnet, Dariouch Dolatabadi, Guy Verhelst, Eric Vandueren, Eric Dubois, Guy Bruninx, Christian Delcour, Jean-Claude Wautrecht

    Diffuse aortic atherosclerotic disease (AAD) is now well recognized as a potential source of cerebral and peripheral emboli. Its clinical importance has been demonstrated in patients over 60. We focus on an unusual presentation of AAD in younger patients free from significant diffuse aortic atherosclerosis, where the outstanding lesion was a large and highly mobile thrombus. Two cases of mobile aortic thrombi, which were conservatively managed with ticlopidine, a potent antiplatelet agent, are reported. Our two cases suggest a possible place of antiplatelet therapy with thienopyridine in the management of isolated large mobile aortic thrombus.